Alyeska Investment Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-196,752
| Closed | -$767K | – | 566 |
|
2018
Q1 | $767K | Buy |
+196,752
| New | +$767K | 0.01% | 372 |
|
2017
Q3 | – | Sell |
-466,529
| Closed | -$1.54M | – | 573 |
|
2017
Q2 | $1.54M | Buy |
+466,529
| New | +$1.54M | 0.01% | 348 |
|
2016
Q3 | – | Sell |
-78,949
| Closed | -$268K | – | 573 |
|
2016
Q2 | $268K | Buy |
78,949
+1,602
| +2% | +$5.44K | ﹤0.01% | 402 |
|
2016
Q1 | $411K | Buy |
77,347
+2,347
| +3% | +$12.5K | ﹤0.01% | 359 |
|
2015
Q4 | $923K | Buy |
+75,000
| New | +$923K | 0.01% | 335 |
|